Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats
2011

Palmitoylethanolamide Reduces Pain in Rats

Sample size: 12 publication 10 minutes Evidence: moderate

Author Information

Author(s): De Filippis Daniele, Luongo Livio, Cipriano Mariateresa, Palazzo Enza, Cinelli Maria Pia, de Novellis Vito, Maione Sabatino, Iuvone Teresa

Primary Institution: Department of Experimental Pharmacology, Faculty of Pharmacy, University of Naples Federico II

Hypothesis

The study aims to investigate the analgesic role of palmitoylethanolamide (PEA) in chronic granulomatous inflammation sustained by mast cell activation in rats.

Conclusion

PEA significantly reduces pain perception by modulating mast cell activation in a rat model of chronic inflammation.

Supporting Evidence

  • PEA reduced the expression and release of NGF in comparison with saline-treated controls.
  • PEA prevented nerve formation and sprouting, as shown by histological analysis.
  • PEA significantly reduced mast cell degranulation and nerve fiber formation.

Takeaway

This study shows that a substance called palmitoylethanolamide can help reduce pain in rats with inflammation by affecting certain cells in the body.

Methodology

Rats were treated with different concentrations of PEA, and pain responses were measured using Von Frey filaments and histological analysis of granulomatous tissue.

Potential Biases

Potential bias in the interpretation of results due to the animal model used.

Limitations

The study is limited to an animal model and may not directly translate to human conditions.

Participant Demographics

Male Wistar rats, weighing 200-220 g.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1744-8069-7-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication